Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

[1]  Jagmeet P. Singh,et al.  Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. , 2013, European heart journal.

[2]  Erwan Donal,et al.  Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. , 2012, European heart journal.

[3]  S. Faerestrand,et al.  A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy , 2012, European journal of heart failure.

[4]  A. Baranchuk,et al.  The Right Ventricular Septum Presents the Optimum Site for Maximal Electrical Separation During Left Ventricular Pacing , 2012, Journal of cardiovascular electrophysiology.

[5]  C. Keyl,et al.  Acute Hemodynamic Effects of Right and Left Ventricular Lead Positions during the Implantation of Cardiac Resynchronization Therapy Defibrillators , 2011, Pacing and clinical electrophysiology : PACE.

[6]  L. Rohde,et al.  Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care? , 2011, Journal of cardiac failure.

[7]  A. Baranchuk,et al.  559 Maximal electrical separation (MES)-guided placement of right ventricular (RV) lead improves responders in cardiac resynchronization defibrillator therapy (CRT-D) , 2011 .

[8]  Paul J. Wang,et al.  Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[9]  D. Dutka,et al.  The Impact of the Right Ventricular Lead Position on Response to Cardiac Resynchronization Therapy , 2011, Pacing and clinical electrophysiology : PACE.

[10]  Wojciech Zareba,et al.  Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.

[11]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[12]  S. Solomon,et al.  Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy , 2010, Circulation.

[13]  Takeshi Aiba,et al.  Electrical remodeling in the failing heart , 2010, Current opinion in cardiology.

[14]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[15]  M. Gold,et al.  Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.

[16]  J. Kautzner,et al.  Optimization of right ventricular lead position in cardiac resynchronisation therapy ☆ , 2006, European journal of heart failure.

[17]  T. Murohara,et al.  Does RV Lead Positioning Provide Additional Benefit to Cardiac Resynchronization Therapy in Patients with Advanced Heart Failure? , 2006, Pacing and clinical electrophysiology : PACE.

[18]  Wojciech Zareba,et al.  Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[19]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[20]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[21]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[22]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[23]  W. Zareba.  Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure. , 2010, Cardiology journal.